FDA Drug Application (018703) for ZANTAC 300 by GLAXO GRP LTD

Back to FDA Applications sponsored by GLAXO GRP LTD

Application Number018703
Product Number002
FormTABLET;ORAL
DosageEQ 300MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameZANTAC 300
Active IngredientRANITIDINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient RANITIDINE HYDROCHLORIDE7


Back to FDA Applications sponsored by GLAXO GRP LTD